Registry of Lobbyists
Version 3 of 40 (2008-06-06 to 2009-05-13) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.
| Corporation: |
Pfizer Canada ULC
17,300 TRANS-CANADA HIGHWAY KIRKLAND, QC H9J 2M5 Canada |
| Telephone number: | 514-426-7417 |
| Fax number: | 514-426-6835 |
| Responsible officer name and position during the period of this registration: | Paul Lévesque, Président et chef de la direction |
| Description of activities: | Pfizer discovers, develops, manufactures and markets prescription medicines for humans and animals. |
| The client is a subsidiary of the following parent companies: |
PFIZER INC
235 EAST 42ND STREET NEW YORK, NY United States of America 10017-5755 |
| Coalition | The corporation is not a member of a coalition. |
| Subsidiary: | The corporation does not have any subsidiaries that could be affected by the outcome of the undertaking. |
| Other direct interests | The corporation's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking. |
| Was the corporation funded in whole or in part by any domestic or foreign government institution in the last completed financial year? | No |
| Name: | Toni Bothwell |
| Position title: | Site Leader PGM Orangeville PAH |
| Public offices held: | No |
| Name: | David Fortier |
| Position title: | Director, Strategy & Health Policy |
| Public offices held: | No |
| Name: | Nicolas Gagnon |
| Position title: | Manager, Pricing |
| Public offices held: | Yes |
| Name: | John Helou |
| Position title: | Vice President, Public Affairs & Stakeholder Relations |
| Public offices held: | No |
| Name: | Steven Hogue |
| Position title: | Manager, Federal Relations |
| Public offices held: | Yes |
| Name: | Paul Lévesque |
| Position title: | President & CEO |
| Public offices held: | No |
| Name: | Darren Noseworthy |
| Position title: | Vice President & General Counsel |
| Public offices held: | No |
| Name: | Bernard Prigent |
| Position title: | Vice President and Medical Director |
| Public offices held: | No |
| Federal departments or organizations which have been or will be communicated with during the course of the undertaking: | Aboriginal Affairs and Northern Development Canada, Agriculture and Agri-Food Canada (AAFC), Canadian Agency for Drugs and Technologies in Health (CADTH), Canadian Expert Drug Advisory Committee (CEDAC), Canadian Heritage (PCH), Canadian Institute for Health Research, Canadian International Development Agency (CIDA), Competition Tribunal (CT), Federal Office of Regional Development – Quebec (FORD[Q]), Finance Canada (FIN), Foreign Affairs and International Trade Canada (DFAITC), Health Canada (HC), Industry Canada, Justice Canada (JC), Members of the House of Commons, National Defence (DND), Patented Medicine Prices Review Board (PMPRB), Prime Minister's Office (PMO), Privy Council Office (PCO), Public Works and Government Services Canada, Revenue Canada (RC), Senate of Canada, Treasury Board Of Canada Secretariat (TBS), Veterans Affairs Canada (VAC), Western Economic Diversification Canada (WD) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Communication techniques that have been used or are expected to be used in the course of the undertaking:
|
Grass-roots communication, Informal communications, Meetings, Other types: As part of Industry Associations and Delegations eg. Rx&D, BIOTECanada, Chamber of Commerce, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Subject Matter: Areas of Concern: | Aboriginal Health, Access to Information, Competition Policies and Regulations, Cross-border Trade, Federally-funded Health Benefits Program, Fiscal Policies and Regulations, Health, Health Research Policies, Regulations and Ethnics, Industry, Intellectual Property, Inter-governmental Affairs, International Trade, Pharmaceutical Policies and Regulations, Regional Development, Science and Technology | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Subject Matter: Retrospective: | Informal communications, phone calls, written communications, meetings, presentations with: ministers, members of parliament, senators, political advisors and civil servants. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Subject Matter: Prospective: | Informal communications, phone calls, written communications, meetings, presentations with: ministers, members of parliament, senators, political advisors and civil servants. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Details Regarding the Identified Subject Matter
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Subject matters added through a communication report |
|